ストックスクリーナーアプリを入手
1.82
4.00%
0.07
アフターアワーズ：
1.82
前日終値:
$1.75
開ける：
$1.75
24時間の取引高:
525.77K
Relative Volume:
1.60
時価総額：
$78.17M
収益：
$88.55M
当期純損益:
$-53.21M
株価収益率:
-1.4066
EPS:
-1.2939
ネットキャッシュフロー:
$-29.48M
1週間 パフォーマンス:
+3.41%
1か月 パフォーマンス:
-12.08%
6か月 パフォーマンス:
+28.17%
1年 パフォーマンス:
+8.98%
1日の値動き範囲:
$1.75
$1.855
1週間の範囲:
$1.745
$1.88
52週間の値動き範囲:
$1.13
$2.89
Pulmonx Corp Stock (LUNG) Company Profile
Compare LUNG vs ABT, MDT, SYK, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
LUNG
Pulmonx Corp
|
1.82 | 78.17M | 88.55M | -53.21M | -29.48M | -1.2939 |
ABT
Abbott Laboratories
|
102.45 | 177.28B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
94.63 | 121.04B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
304.40 | 116.76B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
45.58 | 66.06B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
88.29 | 50.89B | 6.30B | 1.07B | 1.09B | 1.8406 |
Pulmonx Corp Stock (LUNG) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-31 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2025-03-10 | 開始されました | D. Boral Capital | Buy |
| 2024-12-11 | ダウングレード | Citigroup | Buy → Neutral |
| 2024-06-04 | 開始されました | Lake Street | Buy |
| 2024-02-23 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2023-09-05 | 開始されました | Craig Hallum | Buy |
| 2023-02-27 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2023-01-03 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2022-12-12 | アップグレード | Citigroup | Neutral → Buy |
| 2022-07-11 | ダウングレード | Citigroup | Buy → Neutral |
| 2022-03-02 | 再開されました | BofA Securities | Neutral |
| 2021-12-08 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2021-04-01 | 開始されました | Citigroup | Buy |
| 2021-03-25 | 開始されました | Piper Sandler | Neutral |
| 2021-03-10 | アップグレード | BofA Securities | Neutral → Buy |
| 2021-01-04 | ダウングレード | BofA Securities | Buy → Neutral |
| 2020-10-26 | 開始されました | BofA Securities | Buy |
| 2020-10-26 | 開始されました | Canaccord Genuity | Buy |
| 2020-10-26 | 開始されました | Morgan Stanley | Equal-Weight |
| 2020-10-26 | 開始されました | Stifel | Buy |
| 2020-10-26 | 開始されました | Wells Fargo | Equal Weight |
すべてを表示
Pulmonx Corp (LUNG) 最新ニュース
Five9 Announces Inducement Award Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
🔥 $LUNC — THE BURN STORY IS STILL ALIVE - Binance
Pulmonx Corp Officer Radhakrishnan Srikanth Sells 14,245 Shares at $2.26 Each (NASDAQ: LUNG) - Kalkine Media
Pulmonx general counsel David Lehman sells $32,393 in stock By Investing.com - Investing.com South Africa
Pulmonx CEO French Glendon E. III Disposes of 41,882 Shares at $2.26 Each - Kalkine Media
Pulmonx CCO Geoffrey Rose sells $17,804 in lung shares By Investing.com - Investing.com South Africa
Pulmonx CCO Geoffrey Rose sells $17,804 in lung shares By Investing.com - Investing.com UK
Pulmonx chief science officer sells $32,192 in stock By Investing.com - Investing.com Australia
Pulmonx chief science officer sells $32,192 in stock By Investing.com - Investing.com South Africa
Pulmonx general counsel David Lehman sells $32,393 in stock By Investing.com - Investing.com Nigeria
Pulmonx CCO Geoffrey Rose sells $17,804 in lung shares By Investing.com - Investing.com Nigeria
Pulmonx CCO Geoffrey Rose sells $17,804 in lung shares - Investing.com
Pulmonx general counsel David Lehman sells $32,393 in stock - investing.com
Pulmonx chief science officer sells $32,192 in stock - Investing.com
Pulmonx chief science officer sells $32,192 in stock By Investing.com - Investing.com India
Pulmonx general counsel David Lehman sells $32,393 in stock By Investing.com - Investing.com Canada
Pulmonx chief science officer sells $32,192 in stock By Investing.com - Investing.com UK
Pulmonx general counsel David Lehman sells $32,393 in stock By Investing.com - Investing.com India
Pulmonx general counsel David Lehman sells $32,393 in stock By Investing.com - Investing.com UK
Insider at Pulmonx (LUNG) sells shares to cover taxes - Stock Titan
Pulmonx (LUNG) exec sells shares to cover RSU taxes - Stock Titan
Pulmonx (LUNG) general counsel sells shares to cover RSU taxes - Stock Titan
Pulmonx Shares Fall Following Recent Gains - Yahoo Finance
Why is Pulmonx stock sliding today? By Investing.com - Investing.com Australia
Why is Pulmonx stock sliding today? - Investing.com
Pulmonx (LUNG) CEO sells 41,882 shares to cover taxes - Stock Titan
Pulmonx Corporation Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
Pulmonx will take investor meetings in Boston and New York Sept. 9-10 - Stock Titan
Pulmonx to Participate in Upcoming Investor Conferences - Yahoo Finance
Pulmonx Corporation (LUNG) Now Trades Above Golden Cross: Time to Buy? - Yahoo Finance
Pulmonx Corporation (LUNG) Now Trades Above Golden Cross: Time to Buy? - Zacks Investment Research
Pulmonx Rebuilds Sales Force, Targets Growth and AeriSeal Launch Next Year - MarketBeat
Pulmonx Corp (NASDAQ: LUNG) Share Price, LUNG Stock News, LUNG Share Price & Updates - Kalkine
What Makes Pulmonx Corporation (LUNG) a Strong Momentum Stock: Buy Now? - Yahoo Finance
Morgan Stanley (LUNG) reports 6.9% Pulmonx stake in updated ownership filing - Stock Titan
Pulmonx at Canaccord Genuity growth conference: turnaround gains pace - Investing.com
Pulmonx (LUNG) Q2 2026 Earnings Call Transcript - The Globe and Mail
Pulmonx Corp 2026: Revenue $22.76M, EPS ($0.24) — 10-Q Summary - TradingView
Pulmonx (LUNG) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance
Earnings Release: Here's Why Analysts Cut Their Pulmonx Corporation (NASDAQ:LUNG) Price Target To US$3.40 - Sahm
LUNG Looks 82.5% Undervalued on GF Value™ Despite Financial Chal - GuruFocus
Pulmonx Target of Unusually Large Options Trading (NASDAQ:LUNG) - MarketBeat
Earnings call transcript: Pulmonx tops Q2 2026 estimates, shares jump 14.4% - Investing.com
Pulmonx Q2 Revenue Falls 5 Percent To $22.8 Million - Quiver Quantitative
Pulmonx Reports Second Quarter 2026 Financial Results - Yahoo Finance
Pulmonx's Aug. 11 Boston fireside chat will be webcast live - Stock Titan
LUNG|Pulmonx Corp|Price:1.225|Chg%:+0.055 - TradingKey
Pulmonx Corp (LUNG) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Pulmonx Corp expected to post a loss of 28 cents a shareEarnings Preview - TradingView
Pulmonx Reports Q1 2026 Earnings with Strategic Outlook - Intellectia AI
Pulmonx Corp (LUNG) 財務データ
収益
当期純利益
現金流量
EPS
Pulmonx Corp (LUNG) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Lehman David Aaron | General Counsel |
Sep 01 '26 |
Sale |
2.26 |
14,334 |
32,395 |
361,827 |
| Rose Geoffrey Beran | Chief Commercial Officer |
Sep 01 '26 |
Sale |
2.26 |
7,879 |
17,807 |
449,832 |
| Radhakrishnan Srikanth | Chief Science & Techn. Officer |
Sep 01 '26 |
Sale |
2.26 |
14,245 |
32,194 |
316,994 |
| French Glendon E. III | President and CEO |
Jun 02 '26 |
Sale |
1.57 |
13,511 |
21,212 |
1,178,162 |
| Lehman David Aaron | GENERAL COUNSEL |
Jun 01 '26 |
Sale |
1.54 |
14,594 |
22,475 |
376,161 |
| Rose Geoffrey Beran | CHIEF COMMERCIAL OFFICER |
Jun 01 '26 |
Sale |
1.54 |
8,023 |
12,355 |
457,711 |
| French Glendon E. III | President and CEO |
Jun 01 '26 |
Sale |
1.54 |
42,638 |
65,663 |
1,191,673 |
| Radhakrishnan Srikanth | Chief Science &Techn. Officer |
Jun 01 '26 |
Sale |
1.54 |
14,497 |
22,325 |
331,239 |
| Rose Geoffrey Beran | CHIEF COMMERCIAL OFFICER |
Mar 02 '26 |
Sale |
1.43 |
7,732 |
11,057 |
365,734 |
| Radhakrishnan Srikanth | Chief Science &Techn. Officer |
Mar 02 '26 |
Sale |
1.43 |
10,483 |
14,991 |
170,736 |
11.05%
0.41%
大文字化:
|
ボリューム (24 時間):